Sponsor Pipeline

Vera Therapeutics, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
4
Active Trials
1
Recruiting
1
Phase 3
Active Trials by Phase
Phase 3
1
Phase 2
3
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT04716231 Atacicept in Subjects With IgA Nephropathy IgA Nephropathy Active, Not Recruiting
Phase 2
NCT06983028 Atacicept in Multiple Glomerular Diseases pMN Recruiting
NCT07020923 Monthly Dosing of Atacicept in IgAN IgA Nephropathy (IgAN) Active, Not Recruiting
NCT06674577 A Rollover Study to Evaluate the Long-Term Safety and Efficacy of Atacicept IgA Nephropathy (IgAN) Enrolling by Invitation
Get alerts when Vera Therapeutics, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free